Company
Volastra Therapeutics
Short Circuiting Cancer's Chaos
Also known as Volastra Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- New York City, New York, United States
- Legal name
- Volastra Therapeutics, Inc.
- volastratx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Volastra is an NYC-based clinical stage biotechnology company dedicated to the discovery and development of oncology therapeutics targeting chromosomal instability, or CIN, a key vulnerability of cancers.
Funding snapshot
- Total raised
- $105MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $30.1M2025-09-08
Funding rounds
- Round, 2025
- $30.1M2025-09-08, SEC form D sold, 11 investors
- Round, 2024
- $15M2024-05-17, SEC form D sold, 2 investors
- Round, 2023
- $60.2M2023-03-03, SEC form D sold, 13 investors
Loading relationship preview